|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.33 USD | +2.38% |
|
-0.10% | -34.58% |
| 06-20 | Bayer, Orion's Prostate Cancer Treatment Recommended for EU Approval in Third Indication | MT |
| 06-20 | Orion Receives $100 Million in New Contracts | MT |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- OEC Stock
- News Orion S.A.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition